Three major U.S. drug distributors requested the government to expand the Covid-19 vaccine supply chain network as the country strives to immunize its population against the novel coronavirus as quickly as possible.
The COVID-19 pandemic has redefined what it means and what it takes to be a healthcare provider in a time of crisis. In a new study from McCann Health, the data from the original 2016 Truth About Doctors study was re-examined and updated, highlighting the need to focus on prioritizing the health and wellbeing of physicians to ultimately help foster a healthier public.
The world’s largest syringe maker does not have the capacity to substantially increase U.S. supplies of specialty syringes needed to squeeze more doses from Pfizer Inc. Covid-19 vaccine vials in the coming weeks, an executive said in an interview.
U.S. Surgeon General Jerome Adams pleaded with Americans to grasp “the severity of the moment” and remain vigilant against the coronavirus pandemic, as record hospitalizations pushed healthcare professionals to the brink.
The U.S. Food and Drug Administration approved the first Covid-19 self-testing kit for home use that provides results within 30 minutes.
Join this webinar for a compelling presentation from TLD Group Advisor and Senior Consultant Dr. Kent Bottles who discuss American Healthcare in 2021: What Should Providers, Patients, & Citizens Expect?
The U.S. Food and Drug Administration is alerting clinical laboratory staff and healthcare providers that false positive results can occur with Covid-19 antigen tests.
W2O announced two new products available through Symplur, the company’s social media analytics platform dedicated exclusively to the healthcare industry.
Healthcare providers – including CVS Health Corp. – are kicking off flu vaccinations early, ordering extra shots and aiming to add tests that check for both the annual flu and COVID-19, pharmacy executives and experts told Reuters.
AbbVie Inc. agreed to pay $24 million to settle a lawsuit that alleged insurance fraud by the drugmaker in promoting the company’s blockbuster drug Humira, California’s insurance regulator said.